GlassScriptPhysician profile
John R Roost
NPI 1083988877
$7,706.74
in general payments reported to CMS, 2019-2025
35 companies · $83.88 in 2025
The $83.88 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $4,506 · 2021: $616 · 2022: $629 · 2023: $829 · 2024: $351 · 2025: $83.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,932.45 | 2020-2022 | |
| Acessa Health INC. | $996.92 | 2020 | |
| Coopersurgical, INC. | $634.74 | 2019-2021 | |
| Abbvie INC. | $540.33 | 2019-2023 | Orilissa |
| Aspira Women'S Health INC | $263.34 | 2023-2025 | Ova1 |
| Myovant Sciences INC. | $250.69 | 2021-2022 | |
| Hologic Sales and Service, LLC | $214.52 | 2019-2025 | Acessa Provu System, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $174.14 | 2023 | Myfembree |
| Channel Medsystems, INC. | $164.59 | 2023-2024 | |
| Daiichi Sankyo INC. | $161.41 | 2019-2023 | Injectafer |
| Davol INC. | $158.16 | 2019-2021 | |
| Therapeuticsmd, INC. | $137.42 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.82 | 2022-2025 | |
| Exeltis, USA INC. | $96.36 | 2020-2023 | Slynd |
| Pfizer INC. | $92.86 | 2022-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $87.82 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lupin INC. | $75.81 | 2019-2020 | |
| Astellas Pharma US INC | $70.91 | 2023 | Veozah |
| Novo Nordisk INC | $69.86 | 2020-2021 | |
| Ethicon US, LLC | $62.93 | 2020 | |
| Gynesonics, INC. | $58.43 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mylan Pharmaceuticals INC. | $51.07 | 2020-2021 | |
| Smith+Nephew, INC. | $44.38 | 2019-2023 | Pico 7 |
| Agile Therapeutics, INC. | $41.15 | 2022 | |
| Avion Pharmaceuticals | $39.99 | 2020-2022 | |
| Organon LLC | $30.70 | 2023 | Nexplanon |
| Sage Therapeutics, LLC | $23.39 | 2024 | |
| Amag Pharmaceuticals, INC. | $20.89 | 2019 | |
| Meditrina | $19.25 | 2022 | |
| Amgen INC. | $17.66 | 2022 | |
| Merck Sharp & Dohme LLC | $17.61 | 2020 | |
| Minerva Surgical, INC | $14.90 | 2023 | |
| Boston Scientific Corporation | $13.81 | 2019 | |
| Exact Sciences Corporation | $13.27 | 2024 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.